Advisory Board Co (ABCO) Files Form 4 Insider Selling : Michael T Kirshbaum Sells 2,400 Shares

Advisory Board Co (ABCO): Michael T Kirshbaum , Chief Financial Officer of Advisory Board Co sold 2,400 shares on Sep 20, 2016. The Insider selling transaction was reported by the company on Sep 22, 2016 to the Securities and Exchange Commission. The shares were sold at $43.01 per share for a total value of $103,224.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 16, 2016, Cormac F Miller (Chief Product Officer) sold 1,500 shares at $43.04 per share price.On Sep 14, 2016, Robert W Musslewhite (Chief Executive Officer) sold 5,500 shares at $43.09 per share price.Also, On Aug 24, 2016, Michael T Kirshbaum (Chief Financial Officer) sold 2,400 shares at $41.53 per share price.On Aug 18, 2016, Peter J Grua (director) sold 2,500 shares at $41.44 per share price.

The Advisory Board Company: On Tuesday, Sep 21, 2016 heightened volatility was witnessed in The Advisory Board Company which led to swings in the share price. The shares opened for trading at $43.25 and hit $43.29 on the upside , eventually ending the session at $42.99, with a gain of 0.16% or 0.07 points. The heightened volatility saw the trading volume jump to 1,55,660 shares. The 52-week high of the share price is $54.835 and the company has a market cap of $1,731 M . The 52-week low of the share price is at $18.87.

The Advisory Board Company Money Flow Index Chart

Company has been under the radar of several Street Analysts.The Advisory Board Company is Upgraded by Craig Hallum to Buy. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Jul 28, 2016.The Advisory Board Company is Reiterated by FBR Capital to Mkt Perform and the brokerage firm has raised the Price Target to $ 37 from a previous price target of $35 .The Rating was issued on Jul 28, 2016.The Advisory Board Company is Downgraded by Raymond James to Mkt Perform. Earlier the firm had a rating of Outperform on the company shares. The Rating was issued on Jul 19, 2016.

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues including physician alignment and engagement network management and growth strategy value-based care and population health revenue cycle clinical operations and supply chain. Its higher education programs support colleges and universities in enrollment management academic programming and student learning faculty recruitment and retention student advising and success alumni affairs and advancement and college and university operations. The Company offers approximately 65 distinct membership programs across four areas which include best practices research and insight performance technology software consulting and management services and data- and tech-enabled services. Its best practices research and insight programs provide the foundation for all of its other programs.

Leave a Reply

The Advisory Board Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on The Advisory Board Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.